Ready for the next step in nuclear medicine? The ANZSNM 2025 Annual Scientific Meeting is coming up! Join us to explore advancements and connect with experts. 📅 Save the date: 23 – 25 May 2025 📍 Melbourne Convention Centre. Register now! 🔗 https://t.co/VO37FvBj1N #ANZSNM2025
What a pleasure to speak at the @ASMIRTorg Masterclass at Adelaide Hills Convention Centre, Hahndorf. A great afternoon, representing the @anzsnm1969 and connecting with other Medical Radiation Practitioners.
Great work by our PhD student, @RyanJalleh and colleagues. @CRENutrition@UniofAdelaide
Gastrointestinal effects of GLP-1 receptor agonists: mechanisms, manag... https://t.co/F0phuebotP
Travel grants also available to support attendance by nurses, allied health practitioners and other members of the theranostics team involved in the care of patients from around Australia (including regional and remote regions) - https://t.co/L80uVeTcbI
Check out our latest paper published in Diabetes Research & Clinical Practice about the sex differences in glucagon responses after a mixed meal and an oral glucose load in people with type 2 diabetes. https://t.co/Rer31fdOwz
@CongXie7@DrTongzhi@CRENutrition@Prof_KL_Jones
One of our latest papers showing variability and marked delay in gastric emptying after 8 weeks treatment with a short-acting GLP-1 receptor agonist in type 2 diabetes
https://t.co/n8kUhJGpc8 via @practiceupdate
@josh_kovoor@DrTongzhi@RyanJalleh@CRENutrition
More new about our paper - Timing of Metformin Important in Metformin-Treated Type 2 Diabetes https://t.co/vZ6IhRdsP3 via @practiceupdate @DrTongzhi@CongXie7@CRENutrition
An absolute pleasure to be an international invited speaker at the American Diabetes Association meeting 84th Scientific sessions. Presenting ‘Gastroparesis - Myths and Facts’ #ADASciSesssions in Orlando, Florida
Up front & free to read in our July issue #editorspicks: Impact of the timing of metformin administration on glycaemic and glucagon-like peptide-1 responses to intraduodenal glucose infusion in type 2 diabetes https://t.co/ie4Gdez4Fq